Rating Change
Barclays reiterated its Equal-Weight rating on Sabra Health Care REIT, Inc. (NASDAQ:SBRA) on October 13, 2026.
reiterateNASDAQ:SBRA
Barclays Reiterates Equal-Weight Rating on Sabra Health Care REIT, Inc. (SBRA)
Barclays reiterated its Equal-Weight rating on Sabra Health Care REIT, Inc. (NASDAQ:SBRA) on October 13, 2026.
At publication ·
What changed
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) · reiterate
- Firm
- Barclays
- Rating
- Equal-Weight to Equal-Weight
- Price at event
- $19.31
- Market capitalization
- $4.5B
At a glance
Key takeaways
- Barclays reiterated an Equal-Weight rating on Sabra Health Care REIT (SBRA) on October 13, 2026, indicating neutral analyst sentiment.
Market Context
Sabra Health Care REIT, Inc. operates in the Real Estate sector. The stock currently trades at $19.31 with a market capitalization of $4.5B. The stock has gained 8.8% over the past 52 weeks.
Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Sabra Health Care REIT, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Sabra Health Care REIT, Inc.
Among the 10 most recent ratings: 3 Buy, 7 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 13, 2026 | Barclays | Equal-Weight | N/A |
| Aug 31, 2026 | Barclays | Equal-Weight | N/A |
| Aug 31, 2026 | Baird | Neutral | N/A |
| Aug 06, 2026 | Raymond James | Market Perform | N/A |
| Jul 22, 2026 | Citizens | Market Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View SBRA Stock Page
Frequently Asked Questions
What does the Equal-Weight rating mean for SBRA?
A rating of Equal-Weight from Barclays reflects the analyst's outlook on Sabra Health Care REIT, Inc. (NASDAQ:SBRA). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the SBRA forecast page.